Sutro Biopharma is undergoing a seismic shake-up—jettisoning its CEO, half of its workforce, its lead candidate and its manufacturing facility in a major bid to save cash. The almost 50% layoffs ...

Sutro Biopharma, a South San Francisco company working to design anti-cancer drugs, is a fresh face for biotech’s extreme risk — and its fallout. As of this year, the company had racked up ...

The layoffs, which are permanent according to state filings, will see three people lose their jobs at Sutro’s South San Francisco office on Oyster Point Boulevard. Another 62 employees at Sutro ...

SOUTH SAN FRANCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody ...

Sutro Biopharma (STRO) announced the completion of a strategic portfolio review resulting in the prioritization of its three wholly-owned preclinical programs in its next-generation ADC pipeline ...